The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 345:377-378 August 2, 2001 Number 5
NextNext

Hematopoietic-Cell Transplantation for Chronic Granulomatous Disease

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
To the Editor: In his editorial (March 22 issue)1 on the treatment of chronic granulomatous disease, Ezekowitz balances the risk of bone marrow transplantation against the benefits of prophylaxis with antimicrobial agents and interferon gamma and cites a recent study from our center. We reported on an unselected group of 21 patients in whom the disease had been diagnosed at our center since 1990, all of whom were alive and well at a mean age of 4.4 years.2 Since this study was published, two of our patients have died from infectious complications of chronic granulomatous disease, despite optimal antibacterial and . . . [Full Text of this Article]

References



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.